Karpus Management, Inc. Tekla Life Sciences Investors Transaction History
Karpus Management, Inc.
- $3.08 Billion
- Q3 2024
A detailed history of Karpus Management, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Karpus Management, Inc. holds 468,598 shares of HQL stock, worth $6.33 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
468,598
Previous 404,384
15.88%
Holding current value
$6.33 Million
Previous $5.73 Million
23.32%
% of portfolio
0.23%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.31MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$46.3 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$10.5 Million0.25% of portfolio
-
Morgan Stanley New York, NY490KShares$6.61 Million0.0% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.63 Million0.14% of portfolio
-
Needham Investment Management LLC New York, NY353KShares$4.76 Million0.43% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...